Metreleptin for treating lipodystrophy (HST14)
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults
Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults
This guideline covers interventions that use a digital or mobile platform to help people eat more healthily, become more active, stop smoking, reduce their alcohol intake or practise safer sex. The interventions include those delivered by text message, apps, wearable devices or the internet. The guideline only includes those that are delivered by the technology itself and not by healthcare professionals using technology to deliver interventions.
Classification: Official Publications approval reference: 001559 1 | Delivery of midwifery intrapartum care in response to exceptional staff shortages
Publications approval reference: 001559 Clinical guidance for healthcare professionals on maintaining immunisation programmes during COVID-19...
Classification: Official Publications approval reference: 001559 Specialty guides for patient management during the coronavirus pandemic Clinical...
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0]
Publications approval reference: 001559 NHS England and NHS Improvement Specialty guides for patient management during the coronavirus pandemic
Publications approval reference: 001559 NHS England and NHS Improvement Specialty guides for patient management during the coronavirus pandemic
Publications approval reference: 001559 Specialty guides for patient management during the coronavirus pandemic Clinical guide for the management
Publications approval reference: 001559 NHS England and NHS Improvement Specialty guides for patient